Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
2.420
-0.080 (-3.20%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Evoke Pharma Employees
Evoke Pharma had 3 employees as of December 31, 2024. The number of employees decreased by 1 or -25.00% compared to the previous year.
Employees
3
Change (1Y)
-1
Growth (1Y)
-25.00%
Revenue / Employee
$3,416,472
Profits / Employee
-$1,784,065
Market Cap
5.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
EVOK News
- 5 weeks ago - Evoke Pharma, Inc. (EVOK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 - GlobeNewsWire
- 2 months ago - Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors - GlobeNewsWire
- 4 months ago - Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends - GlobeNewsWire
- 5 months ago - Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI® - GlobeNewsWire
- 5 months ago - InvestCloud to Partner with Evoke Advisors to Transform Their Digital Experience - Business Wire
- 5 months ago - Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results - GlobeNewsWire